🇮🇱 IMDELLTRA in Israel

IMDELLTRA (TARLATAMAB-DLLE) regulatory status in Israel.

Marketing authorisation

MOH

  • Status: likely_approved

IMDELLTRA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in Israel

Frequently asked questions

Is IMDELLTRA approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for IMDELLTRA in Israel?

AMGEN INC is the originator. The local marketing authorisation holder may differ — check the official source linked above.